Interline Therapeutics Launches With $92 Million to Map and Correct Dysfunctional Protein Communities

SAN FRANCISCO--(BUSINESS WIRE)--Interline Therapeutics, a Foresite Labs incubated company focused on systematically elucidating protein communities to define molecular mechanisms of disease, announced today that the company has raised $92 million. Foresite Capital and ARCH Venture Partners co-led the financing, which will be used to expand the research platform and advance...

Click to view original post